Author details

Full Name

John Sidney

Affiliation

ORCID

Career Start Year

1990

Papers

406

H Index

104

Expertise

CM4AI Collaborator

PMID	Paper Title	Journal Title	Published Year
38070502	Pre-existing SARS-2-specific TÂ cells are predicted to cross-recognize BA.2.86.	Cell Host Microbe	2024
37490913	T cell reactivity to Bordetella pertussis is highly diverse regardless of childhood vaccination.	Cell Host Microbe	2023
37766162	CD4<sup>+</sup> T Cell Responses to <i>Toxoplasma gondii</i> Are a Double-Edged Sword.	Vaccines (Basel)	2023
37726420	Correlative CD4 and CD8 T-cell immunodominance in humans and mice: Implications for preclinical testing.	Cell Mol Immunol	2023
37968794	Thioamide Analogues of MHC I Antigen Peptides.	J Am Chem Soc	2023
37966108	The MegaPool Approach to Characterize Adaptive CD4+ and CD8+ T Cell Responses.	Curr Protoc	2023
37964123	Correction: Correlative CD4 and CD8 T-cell immunodominance in humans and mice: implications for preclinical testing.	Cell Mol Immunol	2023
37463205	T cell deletional tolerance restricts AQP4 but not MOG CNS autoimmunity.	Proc Natl Acad Sci U S A	2023
36750314	T Cell Responses to SARS-CoV-2.	Annu Rev Immunol	2023
36993748	Genome-wide characterization of T cell responses to <i>Bordetella pertussis</i> reveals broad reactivity and similar polarization irrespective of childhood vaccination profiles.	bioRxiv	2023
35139340	SARS-CoV-2 vaccination induces immunological T cell memory able to cross-recognize variants from Alpha to Omicron.	Cell	2022
35847273	Predicting the Success of Fmoc-Based Peptide Synthesis.	ACS Omega	2022
35766025	Immunodominant MHC-II (Major Histocompatibility Complex II) Restricted Epitopes in Human Apolipoprotein B.	Circ Res	2022
35957961	High-resolution analysis of individual spike peptide-specific CD4<sup>+</sup> T-cell responses in vaccine recipients and COVID-19 patients.	Clin Transl Immunology	2022
35672132	Immunological Interaction of HLA-DPB1 and Proteinase 3 in ANCA Vasculitis is Associated with Clinical Disease Activity.	J Am Soc Nephrol	2022
35926021	A conserved Bacteroidetes antigen induces anti-inflammatory intestinal T lymphocytes.	Science	2022
36521443	SARS-CoV-2 human TÂ cell epitopes: Adaptive immune response against COVID-19.	Cell Host Microbe	2022
36463861	Defining antigen targets to dissect vaccinia virus and monkeypox virus-specific TÂ cell responses in humans.	Cell Host Microbe	2022
34986197	Correction: Broadly directed SARS-CoV-2-specific CD4+ T cell response includes frequently detected peptide specificities within the membrane and nucleoprotein in patients with acute and resolved COVID-19.	PLoS Pathog	2022
34961636	A promiscuous T cell epitope-based HIV vaccine providing redundant population coverage of the HLA class II elicits broad, polyfunctional T cell responses in nonhuman primates.	Vaccine	2022
34953325	SARS-CoV-2-specific T cell responses and immune regulation in infected pregnant women.	Journal of Reproductive Immunology	2022
34599760	Characterization of SARS-CoV-2 and common cold coronavirus-specific T-cell responses in MIS-C and Kawasaki disease children.	Eur J Immunol	2022
34471285	Functional HPV-specific PD-1<sup>+</sup> stem-like CD8 T cells in head and neck cancer.	Nature	2021
34237248	SARS-CoV-2 human T cell epitopes: Adaptive immune response against COVID-19.	Cell Host Microbe	2021
34230917	Impact of SARS-CoV-2 variants on the total CD4<sup>+</sup> and CD8<sup>+</sup> TÂ cell reactivity in infected or vaccinated individuals.	Cell Rep Med	2021
33688655	Negligible impact of SARS-CoV-2 variants on CD4 [+] and CD8 [+] T cell reactivity in COVID-19 exposed donors and vaccinees.	bioRxiv	2021
33579724	IgG Epitopes Processed and Presented by IgG<sup>+</sup> B Cells Induce Suppression by Human Thymic-Derived Regulatory T Cells.	J Immunol	2021
33521695	Comprehensive analysis of TÂ cell immunodominance and immunoprevalence of SARS-CoV-2 epitopes in COVID-19 cases.	Cell Rep Med	2021
33881854	Backbone Modifications of HLA-A2-Restricted Antigens Induce Diverse Binding and T Cell Activation Outcomes.	J Am Chem Soc	2021
33880475	Generation of a novel SARS-CoV-2 sub-genomic RNA due to the R203K/G204R variant in nucleocapsid: homologous recombination has potential to change SARS-CoV-2 at both protein and RNA level.	bioRxiv	2021
32927123	HLA Class I Binding of Mutant EGFR Peptides in NSCLC Is Associated With Improved Survival.	J Thorac Oncol	2021
33230881	Human rhinovirus-specific CD8 T cell responses target conserved and unusual epitopes.	FASEB J	2021
33064841	Comparison of HLA ligand elution data and binding predictions reveals varying prediction performance for the multiple motifs recognized by HLA-DQ2.5.	Immunology	2021
34571943	Characterization of Conserved and Promiscuous Human Rhinovirus CD4 T Cell Epitopes.	Cells	2021
34495703	Identification and Characterization of Rift Valley Fever Virus-Specific T Cells Reveals a Dependence on CD40/CD40L Interactions for Prevention of Encephalitis.	J Virol	2021
34716313	CD8<sup>+</sup> T cells specific for cryptic apoptosis-associated epitopes exacerbate experimental autoimmune encephalomyelitis.	Cell Death Dis	2021
34379494	Profiling Human Cytomegalovirus-Specific T Cell Responses Reveals Novel Immunogenic Open Reading Frames.	J Virol	2021
34541432	Generation of a Novel SARS-CoV-2 Sub-genomic RNA Due to the R203K/G204R Variant in Nucleocapsid: Homologous Recombination has Potential to Change SARS-CoV-2 at Both Protein and RNA Level.	Pathog Immun	2021
34529740	Broadly directed SARS-CoV-2-specific CD4+ T cell response includes frequently detected peptide specificities within the membrane and nucleoprotein in patients with acute and resolved COVID-19.	PLoS Pathog	2021
31383567	Restricted myeloperoxidase epitopes drive the adaptive immune response in MPO-ANCA vasculitis.	J Autoimmun	2020
32418793	An effective CTL peptide vaccine for Ebola Zaire Based on Survivors' CD8+ targeting of a particular nucleocapsid protein epitope with potential implications for COVID-19 vaccine design.	Vaccine	2020
32183941	A Sequence Homology and Bioinformatic Approach Can Predict Candidate Targets for Immune Responses to SARS-CoV-2.	Cell Host Microbe	2020
31815739	Epitope-specific airway-resident CD4+ T cell dynamics during experimental human RSV infection.	J Clin Invest	2020
32038611	Detection of EXP1-Specific CD4+ T Cell Responses Directed Against a Broad Range of Epitopes Including Two Promiscuous MHC Class II Binders During Acute <i>Plasmodium falciparum</i> Malaria.	Front Immunol	2020
32714104	Candidate Targets for Immune Responses to 2019-Novel Coronavirus (nCoV): Sequence Homology- and Bioinformatic-Based Predictions.	SSRN	2020
33198381	Identification of Novel Yellow Fever Class II Epitopes in YF-17D Vaccinees.	Viruses	2020
32753554	Selective and cross-reactive SARS-CoV-2 T cell epitopes in unexposed humans.	Science	2020
33131981	Epitope prediction and identification- adaptive T cell responses in humans.	Semin Immunol	2020
32571843	Impact of Cysteine Residues on MHC Binding Predictions and Recognition by Tumor-Reactive T Cells.	J Immunol	2020
33330869	Comprehensive analysis of T cell immunodominance and immunoprevalence of SARS-CoV-2 epitopes in COVID-19 cases.	bioRxiv	2020